Merck (MRK) plans to lay off more than 100 scientific staff as it scraps its GBP 1B research center in London, The Financial Times’ Hannah Kuchler and Patrick Temple-West report. Merck will move the research activity to existing sites, mainly in the U.S., telling the FT that “Simply put, the UK is not internationally competitive.” The research center in King’s Cross was already under construction and due to open in 2027.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Omnicom, WPP under pressure after Trump moves to regulate pharma ads
- Trump Trade: U.S. President signs new pharma order
- Trump signs memorandum mandating pharma ads give more info on risks
- Merck & Co. Closes $6 Billion Notes Offering
- Daiichi, Merck announce results from phase 2 trial of ifinatamab deruxtecan